This is mainly attributed to the high affinity of the antibody and to the SN-38 payload release in the tumor microenvironment without internalization or enzymatic cleavage from the antibody, leading to a bystander effect, regardless of TROP2 expression. This evidence concerns the gene TACSTD2 and neoplasm.